BPC-157
BPC-157
Also known as: BPC, Bepecin, PL 14736, PL-10
Overview
Key Facts
Primary Goal: A pentadecapeptide derived from human gastric juice that accelerates healing of tendons, ligaments, muscles, and the GI tract
A pentadecapeptide derived from human gastric juice that accelerates healing of tendons, ligaments, muscles, and the GI tract. One of the most widely researched healing peptides with robust animal data. Half-Life 4 hours (estimated) Typical Dose 250–500 mcg Frequency 1-2x daily Cycle Length 4-12 weeks
Dosing Information
Half-Life
4 hours (estimated)
Typical Dose
250–500 mcg
Frequency
1-2x daily
Cycle Length
4-12 weeks
Administration Routes:
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
Extensively studied in animal models with over 100 published studies demonstrating healing effects on tendons, ligaments, muscles, bone, and GI tissue. Phase 2 clinical trials have been conducted for inflammatory bowel disease. No lethal dose identified in toxicology studies.
Frequently Asked Questions
Common questions about BPC-157
UK-Specific Information
Exclusive data points and guidance for UK residents using BPC-157
UK Lab Testing
US Lab Testing
Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.